RESULTS OF TENEKTEPLASE USE IN MASSIVE PULMONARY THROMBOEMBOLISM. CLINICAL CASE
Pulmonary thromboembolism (PTE) — a life-threatening condition that can lead to death at any age. PTE — is not an independent disease, but it is a complication of venous thromboembolism. Conflicting opinions about the possibility of using tissue plasminogen activator (tenekteplase) expressed in the...
| Published in: | Рациональная фармакотерапия в кардиологии |
|---|---|
| Main Authors: | , , |
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2016-01-01
|
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/690 |
